PEOPLE - Visible Genetics makes appointment:
This article was originally published in Clinica
Visible Genetics has appointed Richard Daly executive vice-president with effect from April 1. Mr Daly was chairman and CEO of Clinical Partners, an HIV disease management company, before joining the Canadian developer of automated DNA sequencing systems and gene-analysis kits.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.